tiprankstipranks

John L. Higgins Insider Profile

4 Followers
John L. Higgins, Director at Ligand Pharma, holds 42.61K shares in Bio-Techne (Ticker: TECH), holds 2.62M shares in OmniAb (Ticker: OABI), holds 417.69K shares in Ligand Pharma (Ticker: LGND).
tipranks
John L. Higgins

John L. Higgins
Ligand Pharma (LGND)
Director

Ranked #79,183 out of 97,983 Corporate Insiders

Profitable Transactions

29%
8 out of 28 Profitable Transactions

Average Return

-8.20%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$52M
73.74%
20.41%
5.85%
0.00%
A breakdown of John L. Higgins's holdings

Insider Roles

Ligand Pharma
(LGND)
Director
OmniAb
(OABI)
Director
Bio-Techne
(TECH)
Director
BioCryst
(BCRX)
Director
Roles that John L. Higgins holds in companies

Most Profitable Insider Trade

Stock:
Ligand Pharma
(LGND)
Rating:Informative Buy
Date:Aug 15, 2014 - Aug 15, 2015
Return:+66.30%
The most profitable trade made by John L. Higgins

John L. Higgins's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Ligand Pharma
Dec 30, 2022
Director
Uninformative Sell
350.61K
$38.31M
OmniAb
Jun 21, 2024
Director
Uninformative Buy
83.80K
$10.60M
Bio-Techne
Jul 10, 2024
Director
Uninformative Buy
137.70K
$3.04M
BioCryst
Director
$0.00
List of latest transactions for each holding click on a transaction to see John L. Higgins's performance on stock

John L. Higgins insider profile FAQ

What is the percentage of profitable transactions made by John L. Higgins?
The percentage of profitable transactions made by John L. Higgins is 29%.
    What is the average return per transaction made by John L. Higgins?
    The average return per transaction made by John L. Higgins is -8.20%.
      What stocks does John L. Higgins hold?
      John L. Higgins holds: LGND, OABI, TECH, BCRX stocks.
        What was John L. Higgins’s latest transaction?
        John L. Higgins latest transaction was an Uninformative Buy of $137.70K.
          What was John L. Higgins's most profitable transaction?
          John L. Higgins’s most profitable transaction was an Informative Buy of LGND stock on August 15, 2014. The return on the trade was 66.30%.
            What is John L. Higgins's role in Ligand Pharma?
            John L. Higgins's role in Ligand Pharma is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.